Mazzaferro S, Coen G, Ballanti P, Bondatti F, Bonucci E, Pasquali M, Sardella D, Tomei E, Taggi F
Department of Nephrology, University La Sapienza, Rome, Italy.
Nephron. 1990;56(3):261-6. doi: 10.1159/000186151.
To evaluate the relationship between hyperparathyroid bone X-ray lesion, biochemical parameters and bone histology in chronic renal failure, 59 patients (52 +/- 14.9 years; Crs 4.7 +/- 2.2 mg/dl, mean +/- SD) on conservative treatment and 103 (48 +/- 14 years) on hemodialysis (from 48.4 +/- 36.7 months) were studied. Right-hand X-ray was carried out for evaluation of the scores (0-3) of acroosteolysis (score A) and subperiosteal resorption (score B). Serum iPTH, osteocalcin and alkaline phosphatase (AP) were measured. In addition in a subset of 53 patients, 30 in predialysis and 23 in dialysis, a bone biopsy was performed for histomorphometry. In predialysis the scores A and B correlated with bone GLA protein (BGP) (p less than 0.01), AP (p less than 0.05) and osteoid surface (p less than 0.05) and 0.01 respectively). In hemodialysis the same level of significant correlation (p less than 0.001) was found between the scores and the three humoral parameters. Score A correlated with active osteoblastic surface and active resorption surface while score B correlated with active osteoblastic surface (p less than 0.01), osteoid surface and active resorption surface (p less than 0.05). Multiple regression analysis carried out to establish the predictive variables of bone histologic lesions (active resorption surface and active osteoblastic surface) singled out BGP in predialysis and AP and the two scores in dialysis. We conclude that serum BGP, as compared to PTH and AP, prevails as a valid marker of hyperparathyroid bone lesion in predialysis, while in dialysis it does not seem to add further information to that carried by other variables.(ABSTRACT TRUNCATED AT 250 WORDS)
为评估慢性肾衰竭患者甲状旁腺功能亢进骨X线病变、生化参数与骨组织学之间的关系,我们对59例接受保守治疗的患者(年龄52±14.9岁;血肌酐4.7±2.2mg/dl,均值±标准差)以及103例接受血液透析的患者(年龄48±14岁,透析时间48.4±36.7个月)进行了研究。进行右手X线检查以评估肢端骨质溶解(评分A)和骨膜下吸收(评分B)的得分(0 - 3分)。检测血清全段甲状旁腺激素(iPTH)、骨钙素和碱性磷酸酶(AP)。此外,在53例患者的亚组中,30例为透析前患者,23例为透析患者,进行了骨活检以进行组织形态计量学分析。在透析前,评分A和B分别与骨钙素(BGP)(p<0.01)、AP(p<0.05)和类骨质表面(p<0.05和0.01)相关。在血液透析患者中,评分与这三个体液参数之间也存在相同水平的显著相关性(p<0.001)。评分A与活跃成骨表面和活跃吸收表面相关,而评分B与活跃成骨表面(p<0.01)、类骨质表面和活跃吸收表面(p<0.05)相关。进行多元回归分析以确定骨组织学病变(活跃吸收表面和活跃成骨表面)的预测变量,结果显示透析前为BGP,透析时为AP和两个评分。我们得出结论,与甲状旁腺激素和AP相比,血清BGP在透析前是甲状旁腺功能亢进骨病变的有效标志物,而在透析时,它似乎并未为其他变量所携带的信息增添更多内容。(摘要截短于250字)